Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

NCT00193219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Bevacizumab
DRUG: Cetuximab
DRUG: 5-fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]